These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29326845)

  • 41. Payment levels, resource use, and insurance risk of medicaid versus private insured in three states.
    Adams EK; Bronstein JM; Becker ER; Hood CR
    J Health Care Finance; 2001; 28(1):72-91. PubMed ID: 11669295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expenditures and use of wraparound health insurance for employed people with disabilities.
    Gettens J; Hoffman D; Henry AD
    Disabil Health J; 2016 Apr; 9(2):248-55. PubMed ID: 26781193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic impact of a Medicaid population health management program.
    Rust G; Strothers H; Miller WJ; McLaren S; Moore B; Sambamoorthi U
    Popul Health Manag; 2011 Oct; 14(5):215-22. PubMed ID: 21506728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advanced diagnostic imaging in privately insured patients: recent trends in utilization and payments.
    Horný M; Burgess JF; Horwitt J; Cohen AB
    J Am Coll Radiol; 2014 Jul; 11(7):692-7. PubMed ID: 24813748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What can the Canadians and Americans learn from each other's health care systems?
    Weil TP
    Int J Health Plann Manage; 2016 Jul; 31(3):349-70. PubMed ID: 27469581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Declining Utilization and Inflation-Adjusted Expenditures for Epidural Procedures in Chronic Spinal Pain in the Medicare Population.
    Manchikanti L; Pampati V; Soin A; Sanapati MR; Kaye AD; Hirsch JA
    Pain Physician; 2021 Jan; 24(1):1-15. PubMed ID: 33400424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations.
    Nair KV; Tang B; Van Den Bos J; Zhang V; Saseen JJ; Naim A; Rahman M
    Curr Med Res Opin; 2009 Feb; 25(2):303-14. PubMed ID: 19192975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost of atopic dermatitis and eczema in the United States.
    Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Stevens SR; Whitaker-Worth DL; Cheng JW; Tong KB
    J Am Acad Dermatol; 2002 Mar; 46(3):361-70. PubMed ID: 11862170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical expenditures associated with diabetes acute complications in privately insured U.S. youth.
    Shrestha SS; Zhang P; Barker L; Imperatore G
    Diabetes Care; 2010 Dec; 33(12):2617-22. PubMed ID: 20843971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. State-level cancer treatment costs: how much and who pays?
    Tangka FK; Trogdon JG; Ekwueme DU; Guy GP; Nwaise I; Orenstein D
    Cancer; 2013 Jun; 119(12):2309-16. PubMed ID: 23559348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical expenditures associated with diabetes among privately insured U.S. youth in 2007.
    Shrestha SS; Zhang P; Albright A; Imperatore G
    Diabetes Care; 2011 May; 34(5):1097-101. PubMed ID: 21525502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health care utilization by children with chronic illnesses: a comparison of medicaid and employer-insured managed care.
    Shatin D; Levin R; Ireys HT; Haller V
    Pediatrics; 1998 Oct; 102(4):E44. PubMed ID: 9755281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in spending and service use after a state autism insurance mandate.
    Saloner B; Barry CL
    Autism; 2019 Jan; 23(1):167-174. PubMed ID: 29126371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health care expenditures for infants and young children with Down syndrome in a privately insured population.
    Boulet SL; Molinari NA; Grosse SD; Honein MA; Correa-Villaseñor A
    J Pediatr; 2008 Aug; 153(2):241-6. PubMed ID: 18534234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk adjustment for Medicare beneficiaries with Alzheimer's disease and related dementias.
    Lin PJ; Maciejewski ML; Paul JE; Biddle AK
    Am J Manag Care; 2010 Mar; 16(3):191-8. PubMed ID: 20225914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance.
    Takvorian SU; Yasaitis L; Liu M; Lee DJ; Werner RM; Bekelman JE
    JAMA Netw Open; 2021 Aug; 4(8):e2119764. PubMed ID: 34342648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Appropriateness of outpatient antibiotic prescribing among privately insured US patients: ICD-10-CM based cross sectional study.
    Chua KP; Fischer MA; Linder JA
    BMJ; 2019 Jan; 364():k5092. PubMed ID: 30651273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes in employer-sponsored health insurance.
    Peele PB; Lave JR; Songer TJ
    Diabetes Care; 2002 Nov; 25(11):1964-8. PubMed ID: 12401740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cost and incidence of prescribing errors among privately insured HIV patients.
    Hellinger FJ; Encinosa WE
    Pharmacoeconomics; 2010; 28(1):23-34. PubMed ID: 20014874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.